Choice of Primary Anesthetic Regimen Can Influence Intensive Care Unit Length of Stay After Coronary Surgery with Cardiopulmonary Bypass
Overview
Authors
Affiliations
Background: Volatile anesthetics protect the myocardium during coronary surgery. This study hypothesized that the use of a volatile agent in the anesthetic regimen would be associated with a shorter intensive care unit (ICU) and hospital length of stay (LOS), compared with a total intravenous anesthetic regimen.
Methods: Elective coronary surgery patients were randomly assigned to receive propofol (n = 80), midazolam (n = 80), sevoflurane (n = 80), or desflurane (n = 80) as part of a remifentanil-based anesthetic regimen. Multiple logistic regression analysis was used to identify the independent variables associated with a prolonged ICU LOS.
Results: Patient characteristics were similar in all groups. ICU and hospital LOS were lower in the sevoflurane and desflurane groups (P < 0.01). The number of patients who needed a prolonged ICU stay (> 48 h) was also significantly lower (propofol: n = 31; midazolam: n = 34; sevoflurane: n = 10; desflurane: n = 15; P < 0.01). Occurrence of atrial fibrillation, a postoperative troponin I concentration greater than 4 ng/ml, and the need for prolonged inotropic support (> 12 h) were identified as the significant risk factors for prolonged ICU LOS. Postoperative troponin I concentrations and need for prolonged inotropic support were lower in the sevoflurane and desflurane group (P < 0.01). Postoperative cardiac function was also better preserved with the volatile anesthetics. The incidence of other postoperative complications was similar in all groups.
Conclusions: The use of sevoflurane and desflurane resulted in a shorter ICU and hospital LOS. This seemed to be related to a better preservation of early postoperative myocardial function.
Chiari P, Fellahi J Front Med (Lausanne). 2024; 11:1424188.
PMID: 38962735 PMC: 11220133. DOI: 10.3389/fmed.2024.1424188.
Abraham A, Elliott C, Abraham M, Ahuja S J Thorac Dis. 2024; 15(12):7042-7049.
PMID: 38249920 PMC: 10797362. DOI: 10.21037/jtd-23-1101.
Baiterek B, Mustafin A Anesth Pain Med. 2023; 13(2):e134119.
PMID: 37601959 PMC: 10439691. DOI: 10.5812/aapm-134119.
Remimazolam for cardiovascular anesthesia.
Hirata N J Anesth. 2023; 37(6):825-827.
PMID: 37584688 DOI: 10.1007/s00540-023-03242-z.
Ma Y, Cao Y, Gao H, Tong R, Yi J, Zhang Z Drug Des Devel Ther. 2023; 17:1719-1732.
PMID: 37333963 PMC: 10275581. DOI: 10.2147/DDDT.S408595.